170 related articles for article (PubMed ID: 35453838)
1. Evaluation of Expressed MicroRNAs as Prospective Biomarkers for Detection of Breast Cancer.
Mohamed AA; Allam AE; Aref AM; Mahmoud MO; Eldesoky NA; Fawazy N; Sakr Y; Sobeih ME; Albogami S; Fayad E; Althobaiti F; Jafri I; Alsharif G; El-Sayed M; Abdelgeliel AS; Abdel Aziz RS
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453838
[TBL] [Abstract][Full Text] [Related]
2. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
3. Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.
Eichelser C; Flesch-Janys D; Chang-Claude J; Pantel K; Schwarzenbach H
Clin Chem; 2013 Oct; 59(10):1489-96. PubMed ID: 23748853
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 21 and microRNA 10b: early diagnostic biomarkers of breast cancer in Egyptian females.
Ali M; El Gayar D; Hany N; Ezzat AH; Zeyada R
J Egypt Natl Canc Inst; 2022 Apr; 34(1):16. PubMed ID: 35399150
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-103a-3p could be a diagnostic and prognostic biomarker for breast cancer.
Liu H; Bian QZ; Zhang W; Cui HB
Oncol Lett; 2022 Jan; 23(1):38. PubMed ID: 34966454
[TBL] [Abstract][Full Text] [Related]
11. Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients.
Ibrahim AM; Said MM; Hilal AM; Medhat AM; Abd Elsalam IM
Tumour Biol; 2020 Oct; 42(10):1010428320963811. PubMed ID: 33028151
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to bilharziasis.
Eissa S; Matboli M; Hegazy MG; Kotb YM; Essawy NO
Transl Res; 2015 Jun; 165(6):731-9. PubMed ID: 25620614
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
14. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
[TBL] [Abstract][Full Text] [Related]
15. Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer.
Peña-Cano MI; Saucedo R; Morales-Avila E; Valencia J; Zavala-Moha JA; López A
Gynecol Obstet Invest; 2019; 84(4):369-377. PubMed ID: 30650411
[TBL] [Abstract][Full Text] [Related]
16. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of microRNA-10b expression in peripheral blood mononuclear cells in evaluating short- and long-term efficacy of chemotherapy for patients with advanced non-small-cell lung cancer.
Yang YL; Wang W; Xu LP
Neoplasma; 2018; 65(4):610-619. PubMed ID: 30064233
[TBL] [Abstract][Full Text] [Related]
18. miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma.
Lopes BC; Braga CZ; Ventura FV; de Oliveira JG; Kato-Junior EM; Bordin-Junior NA; Zuccari DAPC
J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33419057
[TBL] [Abstract][Full Text] [Related]
19. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.
Mar-Aguilar F; Mendoza-Ramírez JA; Malagón-Santiago I; Espino-Silva PK; Santuario-Facio SK; Ruiz-Flores P; Rodríguez-Padilla C; Reséndez-Pérez D
Dis Markers; 2013; 34(3):163-9. PubMed ID: 23334650
[TBL] [Abstract][Full Text] [Related]
20. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
